NCT06712550View on ClinicalTrials.gov

Assessment of Maternal and Fetal Serum Biomarkers in Women With Pre-eclampsia

CompletedOBSERVATIONAL

Enrollment

204

Participants

Timeline

Start Date

December 13, 2024

Primary Completion Date

July 3, 2025

Study Completion Date

July 12, 2025

Conditions

Inflammatory MarkersPreeclampsia SeverePreeclampsia MildUmbilical Cord IssueInflammatory ResponseSerum Seromucoid in PregnancyProtein-bound Hexose in Preeclampsia

Trial Locations (1)

44001

Hawler Medical University, Erbil

All Listed Sponsors

lead

SHAHLA KAREEM ALALAF

OTHER

NCT06712550 - Assessment of Maternal and Fetal Serum Biomarkers in Women With Pre-eclampsia | Biotech Hunter | Biotech Hunter